Brief: Candel Therapeutics Announces Restructuring To Prioritize Resources On Key Value Drivers For Expanded Development Of Can-3110

Candel Therapeutics

28/11/2023 15:32

Nov 28 (Reuters) - Candel Therapeutics Inc  CADL.O :
    * CANDEL THERAPEUTICS ANNOUNCES RESTRUCTURING TO PRIORITIZE
RESOURCES ON KEY VALUE DRIVERS FOR EXPANDED DEVELOPMENT OF
CAN-3110, THE ENLIGHTEN™ DISCOVERY PLATFORM, AND KEY CLINICAL
READOUTS FOR CAN-2409
    * CANDEL THERAPEUTICS INC: REDUCING COMPANY'S WORKFORCE AND
EXPENSES ASSOCIATED WITH ENABLING COMMERCIAL READINESS OF
CAN-2409
    * CANDEL THERAPEUTICS INC - DECREASES WORKFORCE BY
APPROXIMATELY
50%
    * CANDEL THERAPEUTICS INC - EXTENDS CASH RUNWAY INTO Q4 OF
2024

Source text for Eikon:  ID:nGNX4Z1Zh 
Further company coverage:  CADL.O 

 ((Reuters.Briefs@thomsonreuters.com;))